Real life experience with mTOR-inhibitors after lung transplantation

The International Thoracic Organ Transplant Registry of the International Society for Heart and Lung Transplantation: Thirty-sixth adult lung and heart–lung transplantation Report—2019; Focus theme: Donor and recipient size match

Daniel C. Chambers, Wida S. Cherikh, Michael O. Harhay et al. · The Journal of Heart and Lung Transplantation · 2019 · 1.3K citations · Full text

Medicine, Cardiology, Surgery +17

Predictors of Decline in Renal Function After Lung Transplantation

Solomon Menahem, Michael Bailey · The Journal of Heart and Lung Transplantation · 2006 · 62 citations

Medicine, Nephrology, Surgery +14

A randomized trial of everolimus-based quadruple therapy vs standard triple therapy early after lung transplantation

Jens Gottlieb, Claus Neurohr, Joachim Müller‐Quernheim et al. · American Journal of Transplantation · 2019 · 57 citations · Full text

Pharmacy, Nephrology, Pharmacotherapy +17

Long-term outcomes of thoracic transplant recipients following conversion to everolimus with reduced calcineurin inhibitor in a multicenter, open-label, randomized trial

Lars Gullestad, Finn Gustafsson, Gerdt C. Riise et al. · Transplant International · 2016 · 54 citations

Medicine, Pharmacotherapy, Surgery +13

Immunosuppression for Lung Transplantation: Current and Future

Satish Chandrashekaran, Stacy A. Crow, Sadia Shah et al. · Current Transplantation Reports · 2018 · 22 citations

Medicine, Immunology, Surgery +12